Cargando…

Postoperative adjuvant TACE-associated nomogram for predicting the prognosis of resectable Hepatocellular Carcinoma with portal vein Tumor Thrombus after Liver Resection

Background: To explore the effects of postoperative adjuvant transarterial chemoembolization (PA-TACE) on the prognosis of HCC patients with Portal Vein Tumor Thrombus (PVTT) undergoing resection, and to develop a PA-TACE-related nomogram for predicting survival individually. Patients and Methods: T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Fuchen, Guo, Xinggang, Dong, Wei, Zhang, Wenli, Wei, Shuxun, Zhang, Shutong, Zhu, Xiuli, Zhou, Weiping, Zhang, Jinmin, Liu, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645989/ https://www.ncbi.nlm.nih.gov/pubmed/33162826 http://dx.doi.org/10.7150/ijbs.46896

Ejemplares similares

Effect of menopausal status on the survival and recurrence of sex-classified hepatocellular carcinoma after liver resection: a case-matched study with propensity score matching
por: Zhang, Wenli, et al.
Publicado: (2020)

Hepatic resection or transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus
por: Zheng, Ninggang, et al.
Publicado: (2016)

TACE Plus Lenvatinib Versus TACE Plus Sorafenib for Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Prospective Cohort Study
por: Yang, Biao, et al.
Publicado: (2021)

In-hospital Mortality after Surgical Resection in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus
por: Zhang, Xiu-Ping, et al.
Publicado: (2019)

Neoadjuvant radiotherapy for resectable hepatocellular carcinoma with portal vein tumor thrombus: a systematic review
por: Wei, Zhewen, et al.
Publicado: (2022)

Transarterial chemoembolization (TACE) combined with sorafenib versus TACE for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis
por: Zhang, XiuPing, et al.
Publicado: (2017)

A multicenter prospective study of TACE combined with lenvatinib and camrelizumab for hepatocellular carcinoma with portal vein tumor thrombus
por: Li, Xiaomi, et al.
Publicado: (2023)

Probabilistic ratiocination of hepatocellular carcinoma after resection: evaluation of expected to be promising approaches
por: Dong, Wei, et al.
Publicado: (2021)

A prognosis model for patients with hepatocellular carcinoma and portal vein tumor thrombus following hepatic resection
por: XIAO, CHENG-ZUO, et al.
Publicado: (2015)

Downstaging and Conversation Strategy for Advanced Hepatocellular Carcinoma with Portal Vein Branch Tumor Thrombus: TACE, (125)I Seed Implantation, and RFA for Hepatocellular Carcinoma with Portal Vein Branch Tumor Thrombus
por: Zhao, Xiao-Hui, et al.
Publicado: (2023)

Prospective study of TACE combined with sorafenib vs TACE combined with (125)I seed implantation in the treatment of hepatocellular carcinoma with portal vein tumor thrombus and arterioportal fistulas
por: Zhao, Xiao-Hui, et al.
Publicado: (2022)

TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: a propensity score matching study
por: Yuan, Yichuan, et al.
Publicado: (2023)

The Prognostic Comparison Between Hepatocellular Carcinoma with Portal Vein Tumor Thrombus and Bile Duct Cancer Thrombus After Liver Resection
por: Yang, Xin, et al.
Publicado: (2020)

Short-term and long-term outcomes of liver resection for HCC patients with portal vein tumor thrombus
por: Huo, Lei, et al.
Publicado: (2019)

A Combination of Sorafenib, an Immune Checkpoint Inhibitor, TACE and Stereotactic Body Radiation Therapy versus Sorafenib and TACE in Advanced Hepatocellular Carcinoma Accompanied by Portal Vein Tumor Thrombus
por: Zhang, Zeyu, et al.
Publicado: (2022)

Comparison of Liver Transplantation and Liver Resection for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus Type I and Type II
por: Lv, Jia-Yu, et al.
Publicado: (2021)

Comparison of three‐dimensional conformal radiotherapy and hepatic resection in hepatocellular carcinoma with portal vein tumor thrombus
por: Su, Fang, et al.
Publicado: (2018)

Preoperative Decision to Perform Portal Vein Resection Improves Survival in Patients With Resectable Pancreatic Head Cancer Adjacent to Portal Vein
por: Terasawa, Muga, et al.
Publicado: (2021)

Percutaneous thermal ablation combined with TACE versus TACE monotherapy in the treatment for liver cancer with hepatic vein tumor thrombus: A retrospective study
por: Wang, Yang, et al.
Publicado: (2018)

Transarterial Chemoembolization (TACE) Combined with Sorafenib in Treatment of HBV Background Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Propensity Score Matching Study
por: Yuan, Jia, et al.
Publicado: (2019)

Survival benefit of hepatic resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis
por: Zhang, Xiu-Ping, et al.
Publicado: (2017)

PD-1 combined with lenvatinib and TACE for the transformational treatment of hepatocellular carcinoma combined with portal vein tumor thrombus: a case report and literature review
por: Liu, Sheng, et al.
Publicado: (2023)

Correction: Percutaneous thermal ablation combined with TACE versus TACE monotherapy in the treatment for liver cancer with hepatic vein tumor thrombus: A retrospective study
por: Wang, Yang, et al.
Publicado: (2018)

Portal Vein Damage after DEB-TACE and Lipiodol-TACE: Based on Evaluation by Computed Tomography during Arterial Portography
por: Tamura, Masashi, et al.
Publicado: (2021)

DEM-TACE as the initial treatment could improve the clinical efficacy of the hepatocellular carcinoma with portal vein tumor thrombus: a retrospective controlled study
por: Chen, Junwei, et al.
Publicado: (2022)

Selection and Outcome of Portal Vein Resection in Pancreatic Cancer
por: Nakao, Akimasa
Publicado: (2010)

The impact of portal vein resection on outcome of hilar cholangiocarcinoma
por: Kim, Ki Beom, et al.
Publicado: (2021)

Neoadjuvant Three-Dimensional Conformal Radiotherapy for Resectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Randomized, Open-Label, Multicenter Controlled Study
por: Wei, Xubiao, et al.
Publicado: (2019)

Gallbladder cancer with tumor thrombus in the portal vein: A case report
por: Zhang, Xiao-Zhen, et al.
Publicado: (2018)

Significance of Simultaneous Splenic Artery Resection in Left-Sided Portal Hypertension After Pancreaticoduodenectomy with Combined Portal Vein Resection
por: Gyoten, Kazuyuki, et al.
Publicado: (2017)

Intra-arterial ethanol embolization augments response to TACE for treatment of HCC with portal venous tumor thrombus
por: Yang, Biao, et al.
Publicado: (2018)

Correlation and efficacy of TACE combined with lenvatinib plus PD‐1 inhibitor in the treatment of hepatocellular carcinoma with portal vein tumor thrombus based on immunological features
por: Zou, Xinhua, et al.
Publicado: (2023)

Arterialisation of the Portal Vein With an Aortoportal Jump Graft for Portal Vein Thrombosis Following Liver Resection for Malignancy
por: Jiao, Long R., et al.
Publicado: (1999)

Portal vein/superior mesenteric vein resection in pancreatic cancer treatment in the elderly
por: Fang, Jiong-Ze, et al.
Publicado: (2017)

The efficacy and safety of postoperative adjuvant transarterial embolization and radiotherapy in hepatocellular carcinoma patients with portal vein tumor thrombus
por: Bai, Tao, et al.
Publicado: (2016)

Mesenteric-Portal Vein Resection during Pancreatectomy for Pancreatic Cancer
por: Beltrame, Valentina, et al.
Publicado: (2015)

Portal vein resection in advanced pancreatic adenocarcinoma: is it worth the risk?
por: Marsoner, Katharina, et al.
Publicado: (2016)

Effects of portal vein resection and hepatic artery resection on long-term survival in Klatskin tumor: a meta-analysis
por: Song, Yun, et al.
Publicado: (2022)

Surgical Margin Affects the Long-Term Prognosis of Patients With Hepatocellular Carcinoma Undergoing Radical Hepatectomy Followed by Adjuvant TACE
por: Bai, Shilei, et al.
Publicado: (2023)

Irradiation stent with (125)I plus TACE versus sorafenib plus TACE for hepatocellular carcinoma with major portal vein tumor thrombosis: a multicenter randomized trial
por: Lu, Jian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3t4fh7lans8m447rnt5ljke18m